Participant flow18

How many started, completed or left each group, period by period.

1 to 18 of 18

Period	Milestone	Group	Participants
Overall Study	STARTED	UC: Ontamalimab 25 mg	89
Overall Study	STARTED	UC: Ontamalimab 25 mg Then 75 mg	159
Overall Study	STARTED	UC: Ontamalimab 75 mg	268
Overall Study	STARTED	CD: Ontamalimab 25 mg	5
Overall Study	STARTED	CD: Ontamalimab 25 mg Then 75 mg	10
Overall Study	STARTED	CD: Ontamalimab 75 mg	26
Overall Study	COMPLETED	UC: Ontamalimab 25 mg	0
Overall Study	COMPLETED	UC: Ontamalimab 25 mg Then 75 mg	117
Overall Study	COMPLETED	UC: Ontamalimab 75 mg	129
Overall Study	COMPLETED	CD: Ontamalimab 25 mg	0
Overall Study	COMPLETED	CD: Ontamalimab 25 mg Then 75 mg	6
Overall Study	COMPLETED	CD: Ontamalimab 75 mg	12
Overall Study	NOT COMPLETED	UC: Ontamalimab 25 mg	89
Overall Study	NOT COMPLETED	UC: Ontamalimab 25 mg Then 75 mg	42
Overall Study	NOT COMPLETED	UC: Ontamalimab 75 mg	139
Overall Study	NOT COMPLETED	CD: Ontamalimab 25 mg	5
Overall Study	NOT COMPLETED	CD: Ontamalimab 25 mg Then 75 mg	4
Overall Study	NOT COMPLETED	CD: Ontamalimab 75 mg	14

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03283085/flow